Researchers believe they have uncovered the missing link for a dengue vaccine that might halt the deadly mosquito-borne virus that has plagued billions of people since the early 19th century, The Washington Post reports.
The National Institutes of Health developed the vaccine in an intimate, randomized, double-blind trial on 41 healthy participants. Volunteers were injected with the experimental vaccine while others were given a placebo. Six months thereafter, all were given a mild dose of the virus. Those in the placebo group, all 20, experienced rashes, low white blood cell count, and other typical symptoms of the disease, as the 21 vaccinated participants became ill but did not show evidence of infection.
Because of the promising conclusions, a wide-scale Phase 3 test was initiated in Brazil in late February. The target group consists of 17,000 adults, adolescents, and children as the test is expected to be completed in 2018. Scientists were optimistic when they released the results to the press after a conference call. The results were originally published in Science Translational Medicine.
The study’s findings lend hope to a Zika vaccine because both it and dengue are placed in the same classification of viruses, possibly limiting the timeline for a Zika vaccine. Groups of scientists from both the public and private sectors have been trying to develop a vaccine for nearly a century affecting over 400 million people worldwide, as most experience no symptoms.
A vaccine has been a challenge to develop because of the unique structure of the pathogen. Four strains currently circulate the globe with antibodies for each, however, the interaction between them precludes a universal cure exposing the patient to severe risks, a hemorrhagic shock being the worst case scenario.
Human trials are the most effective to test the efficacy of a vaccine but they’re rarely conducted because of ethical concerns to the patient. But scientists assert that this type of observation could be the most eye-opening because they still don’t understand Zika’s inherent traits, such as how long it remains in the blood.
Image credit: Wikipedia Muhammad Mahdi Karim creative commons license CC BY-SA 4.0.